[1]
2020. Evaluation of Soluble PD-1 and PD-L1 in Iraqi Type 2 Diabetes Mellitus (T2DM) Patients with Chronic Toxoplasmosis. Medico Legal Update. 20, 3 (Jul. 2020), 609–615. DOI:https://doi.org/10.37506/mlu.v20i3.1467.